12543677 · Active · incorporated 6 years, 6 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
Purespring Therapeutics is a gene therapy company focused on developing treatments for kidney diseases.
Purespring Therapeutics Limited is a private limited company registered at Companies House under number 12543677, incorporated on 1 April 2020, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 85 filings for this company, including 6 funding rounds. Its most recent round closed in September 2026, raising £17.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Sep 2026 | £17.5m | £0.75 |
| Round 5 | Sep 2025 | £17.6m | £0.75 |
| Round 4 | Oct 2024 | £46.2m | £0.425 |
| Round 3 | Sep 2022 | £16.6m | £1.00 |
| Round 2 | Aug 2021 | £14.6m | £1.00 |
| Round 1 | Dec 2020 | £3.9m | £1.00 |
Showing the 11 most recent of 85 filings.
See the complete cap table with every shareholder, founder tags, dilution across 17 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.